Role Of Fdg Pet-ct In Evaluation Of Gastrointestinal Stromal Tumors

ISBN-13: 9783330326125 / Angielski / Miękka / 2017 / 72 str.

Hosna Moustafa; Gihan El-Hennawy; Esraa El-kholy

Opis

Gastrointestinal stromal tumors (GISTs) are the most frequent mesenchymal tumors of the gastrointestinal tract. A definition of a new entity among the gastrointestinal mesenchymal tumors called the gastrointestinal stromal tumors (GISTs) which express the kit (CD117) protein a growth factor trans-membrane receptor with tyrosine kinase activity. Surgery is the mainstay of therapy for non-metastatic GISTs. The c-kit tyrosine kinase inhibitor Imatinib (Glivec), was found to be useful in treating GISTs, leading to a 40-70% response rate in metastatic or inoperable cases.The current Response Evaluation Criteria in solid tumors are based on uni-dimensional tumor size, and do not take into account changes in responding GISTs such as a decrease in tumor density and decrease in the number of intra-tumoral vessels with CT. PET/CT is highly sensitive in assessment early response to Imatinib mesylate. Also, it is useful in predicting long-term response to imatinib in patients with metastatic GIST; however, widespread use of PET is limited because of cost constraints.

O autorze

Doctorate degree, in (Radiotherapy & Nuclear Medicine) Cairo University, Egypt 1979, Professor of Nuclear Medicine, Faculty of Medicine, Cairo University 1990. Head of AFRA Nuclear Medicine project in Egypt 2003-2017. Head of Egyptian Society of nuclear medicine &Head of Egyptian journal of nuclear medicine 2008-till now.